Enimmune corporation (TPEX:6564)

Enimmune corporation Statistics

Total Valuation

TPEX:6564 has a market cap or net worth of TWD 1.48 billion. The enterprise value is 1.38 billion.

Market Cap	1.48B
Enterprise Value	1.38B

Important Dates

The next estimated earnings date is Friday, April 17, 2026.

Earnings Date	Apr 17, 2026
Ex-Dividend Date	n/a

Share Statistics

TPEX:6564 has 72.13 million shares outstanding. The number of shares has increased by 11.58% in one year.

Current Share Class	72.13M
Shares Outstanding	72.13M
Shares Change (YoY)	+11.58%
Shares Change (QoQ)	-5.14%
Owned by Insiders (%)	0.74%
Owned by Institutions (%)	3.87%
Float	30.85M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	35.01
PB Ratio	6.59
P/TBV Ratio	12.05
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-8.37
EV / Sales	32.64
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-8.19

Financial Position

The company has a current ratio of 1.41, with a Debt / Equity ratio of 0.75.

Current Ratio	1.41
Quick Ratio	1.16
Debt / Equity	0.75
Debt / EBITDA	n/a
Debt / FCF	-0.99
Interest Coverage	-61.49

Financial Efficiency

Return on equity (ROE) is -43.35% and return on invested capital (ROIC) is -22.32%.

Return on Equity (ROE)	-43.35%
Return on Assets (ROA)	-17.78%
Return on Invested Capital (ROIC)	-22.32%
Return on Capital Employed (ROCE)	-74.08%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.06
Inventory Turnover	0.74

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -21.15% in the last 52 weeks. The beta is 0.40, so TPEX:6564's price volatility has been lower than the market average.

Beta (5Y)	0.40
52-Week Price Change	-21.15%
50-Day Moving Average	20.48
200-Day Moving Average	18.81
Relative Strength Index (RSI)	49.02
Average Volume (20 Days)	75,429

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:6564 had revenue of TWD 42.23 million and -164.74 million in losses. Loss per share was -2.22.

Revenue	42.23M
Gross Profit	14.18M
Operating Income	-186.68M
Pretax Income	-167.88M
Net Income	-164.74M
EBITDA	-181.01M
EBIT	-186.68M
Loss Per Share	-2.22

Balance Sheet

The company has 267.50 million in cash and 167.37 million in debt, with a net cash position of 100.13 million or 1.39 per share.

Cash & Cash Equivalents	267.50M
Total Debt	167.37M
Net Cash	100.13M
Net Cash Per Share	1.39
Equity (Book Value)	224.35M
Book Value Per Share	3.11
Working Capital	109.37M

Cash Flow

In the last 12 months, operating cash flow was -166.89 million and capital expenditures -1.52 million, giving a free cash flow of -168.41 million.

Operating Cash Flow	-166.89M
Capital Expenditures	-1.52M
Free Cash Flow	-168.41M
FCF Per Share	-2.33

Margins

Gross Margin	33.56%
Operating Margin	-442.04%
Pretax Margin	-397.53%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TPEX:6564 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.58%
Shareholder Yield	-11.58%
Earnings Yield	-11.14%
FCF Yield	-11.39%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TPEX:6564 has an Altman Z-Score of 1.7 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.7
Piotroski F-Score	1